Maximum Daily Dose of Vertin (Betahistine) for Adults
The maximum daily dose of Vertin (betahistine) for adults is 144 mg per day, administered as 48 mg three times daily, though the standard effective dose is typically 48 mg per day (16 mg three times daily). 1
Standard Dosing Recommendations
- The FDA-approved labeling for Vertin recommends 2 tablets (16 mg) three times daily until symptoms subside, which totals 48 mg per day 2
- This 48 mg daily dose has been extensively studied and demonstrates effectiveness in reducing vertigo frequency and severity in peripheral vestibular disorders 3, 4, 5
High-Dose Betahistine Evidence
- The BEMED trial evaluated high-dose betahistine at 144 mg daily (48 mg three times daily) for Ménière's disease over 9 months and found it well-tolerated with no unexpected safety findings 6
- A 2020 clinical practice guideline for Ménière's disease specifically evaluated both low-dose (48 mg/day) and high-dose (144 mg/day) betahistine regimens 1
- Most clinical studies demonstrate optimal efficacy at 48 mg daily over 3 months for peripheral vertigo, with doses ranging from 32-48 mg showing maximum benefit 3, 5, 7
Dose-Response Considerations
- Doses of 48 mg daily are considered the standard therapeutic dose, with evidence supporting use up to 144 mg daily in refractory cases 1, 6
- The 48 mg daily dose (administered as 16 mg three times daily or 24 mg twice daily) provides the best balance of efficacy and safety for most patients with peripheral vestibular vertigo 4, 5
- Higher doses beyond 144 mg daily have not been adequately studied and should not be exceeded 1, 6
Duration of Treatment
- Treatment duration typically ranges from 3 weeks to 3 months for optimal symptom control, with the 3-month duration showing consistent benefit across multiple studies 3, 5, 7
- The BEMED trial extended treatment to 9 months without safety concerns, suggesting longer-term use is feasible when clinically indicated 6
Safety Profile
- Betahistine demonstrates an excellent safety profile across the dose range of 8-144 mg daily, with more than 40 years of clinical use 5
- Common side effects include headache, balance disorder, nausea, nasopharyngitis, feeling hot, eye irritation, palpitations, and upper gastrointestinal symptoms 1
- Betahistine should be used with caution in patients with asthma, history of peptic ulcer disease, and avoided in patients with pheochromocytoma 1
Clinical Context for Dosing
- For Ménière's disease: 48-144 mg daily has been studied, though the BEMED trial showed no significant difference between doses or placebo in attack frequency 1, 6
- For benign paroxysmal positional vertigo (BPPV): 48 mg daily is used to treat residual dizziness after repositioning maneuvers 3
- For vestibular neuronitis: 48 mg daily stimulates central compensation during vestibular rehabilitation 3
Practical Administration
- The standard regimen is 16 mg three times daily (total 48 mg/day), which can be increased to 48 mg three times daily (total 144 mg/day) if symptoms persist 1, 2, 6
- Tablets can be chewed, dissolved in the mouth, or for small patients, crushed and mixed with warm water or soft food 2
Overdose Management
- In case of overdose, immediate medical attention or contact with a Poison Control Center is required 2